Visiting Researcher At New Jersey-Based Cancer Center Named Winner Of Mallinckrodt Prize For Nuclear Medicine

Named Winner Of Mallinckrodt Prize For Nuclear Medicine Author: Karen Young Kreeger Thomas Behr, 29, a research fellow at the Newark, N.J.-based Garden State Cancer Center who is on leave from the University of Erlangen-Nuremberg, Germany, has received the 1995 Mallinckrodt Prize. The award is given by the German Society of Nuclear Medicine for the best research in that field. He received the prize, which consists of an honorarium of 15,000 DM (approximately $10,000), in late March at the socie

Written byKaren Young Kreeger
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Named Winner Of Mallinckrodt Prize For Nuclear Medicine Author: Karen Young Kreeger

Thomas Behr, 29, a research fellow at the Newark, N.J.-based Garden State Cancer Center who is on leave from the University of Erlangen-Nuremberg, Germany, has received the 1995 Mallinckrodt Prize. The award is given by the German Society of Nuclear Medicine for the best research in that field. He received the prize, which consists of an honorarium of 15,000 DM (approximately $10,000), in late March at the society's annual meeting in Dresden.


International Connections:The goal of visiting scholar Thomas Behr is to share what he learns about radioimmunotherapeutic techniques with his European colleagues.

"It's a great honor to be awarded such a prestigious prize," remarks Behr, who received his M.D. from Erlangen-Nuremberg in 1993. "I think, especially for the field [of nuclear medicine], it's a very big honor that therapy with radiolabeled antibodies is now becoming more recognized ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies